🔍

ACI - Archean Chemical

📊 NSE: ACI 🏢 Chemicals 📅 Last Updated: 12/13/2025 18:28

📢 Recent Corporate Announcements

Archean Chemical Appoints Rampraveen Swaminathan as MD; Shareholders Approve New Leadership

🟡 NEUTRAL ⭐ 6/10

MANAGEMENT 📅 13 Mar 2026, 06:45 PM

Archean Chemical Industries Limited has confirmed the appointment of Mr. Rampraveen Swaminathan as the new Managing Director following a postal ballot. Shareholders also approved the designation of promoter Mr. P. Ranjit as Executive Vice Chairman, although this resolution saw a high 61.5% dissent from public institutions. The voting process concluded on March 12, 2026, with an overall turnout of 78.19%. These leadership changes represent a pivotal shift in the company's top management hierarchy.

Resolution to appoint Rampraveen Swaminathan as Managing Director passed with 96.54% votes in favour.
Mr. P. Ranjit designated as Executive Vice Chairman despite 21.40% total opposition and 61.53% institutional dissent.
Total votes polled reached 96,534,477, accounting for 78.19% of the total 123,458,394 shares.
All three ordinary resolutions were passed with the requisite majority as per the Scrutinizer's Report dated March 13, 2026.

💡 Investors should track the company's strategic direction under the new Managing Director and investigate the reasons behind the significant institutional dissent regarding the Executive Vice Chairman's designation.

Archean Chemical to Attend IIFL's 17th Global Investors' Conference on February 25, 2026

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 19 Feb 2026, 11:54 AM

Archean Chemical Industries Limited (ACI) has announced its participation in IIFL's 17th Enterprising India Global Investors' Conference. The event is scheduled for February 25, 2026, in Mumbai, starting from 10:00 am. The company will engage in 1-on-1 and group meetings with various institutional investors. Management has explicitly stated that no unpublished price sensitive information (UPSI) will be discussed during these sessions.

Participation in IIFL's 17th Enterprising India Global Investors' Conference in Mumbai
Scheduled for February 25, 2026, with meetings starting at 10:00 am
Interaction format includes both 1-on-1 and group meetings with institutional investors
Discussions will be strictly limited to publicly available information

💡 This is a routine investor outreach event; shareholders should look for any investor presentations uploaded post-event for updated business outlooks.

Archean Chemical Q3 FY26: Revenue Up 10%, Salt Volumes Rebound to 1.1 Million Tons

🟡 NEUTRAL ⭐ 7/10

EARNINGS 📅 11 Feb 2026, 10:15 AM

Archean Chemical Industries reported a 10% YoY growth in consolidated revenue for Q3 FY26, with standalone revenue rising 12%. Industrial salt volumes recovered significantly to 1.1 million tons during the quarter, returning to the company's target run rate. The company appointed Mr. Rampraveen Swaminathan as the new Managing Director to lead strategic initiatives, including the semiconductor project in Bhubaneshwar and energy storage ventures. While bromine derivatives utilization remains low at 30-40%, management expects operational stabilization by Q4 FY26.

Consolidated revenue grew 10% YoY in Q3 FY26 and 11% for the 9-month period ended Dec 31, 2025.
Industrial salt segment contributed 70% of standalone revenue with quarterly sales of 1.1 million tons.
Bromine derivatives (Acume) utilization currently at 30-40% with 15 new products in the development pipeline.
SOP plant scale trials are commencing with meaningful financial contributions expected in H2 FY27.
Semiconductor project (SiCSem) has secured a 25-acre site in Bhubaneshwar and completed groundbreaking surveys.

💡 Investors should monitor the utilization levels of the bromine derivatives plant and the execution timeline of the semiconductor project. The recovery in salt volumes is a positive sign, but sustained margin improvement depends on stabilizing bromine prices and successful SOP commercialization.

Archean Chemical Signs MoU with Gujarat Govt for 7 MMTPA Captive Salt Jetty

🟢 POSITIVE ⭐ 7/10

EXPANSION 📅 10 Feb 2026, 07:31 PM

Archean Chemical Industries Limited (ACI) has entered into a Memorandum of Understanding (MoU) with the Government of Gujarat to develop a captive salt jetty and associated infrastructure. The project is designed with a significant throughput capacity of 7 million metric tonnes per annum (MMTPA) along the Gujarat coastline. Under this agreement, the state government will facilitate the necessary regulatory permissions and clearances to expedite the project. This infrastructure development is expected to enhance the company's logistics efficiency and support its large-scale salt export operations.

MoU signed with the Government of Gujarat for a captive salt jetty and infrastructure.
The project features a planned throughput capacity of 7 MMTPA.
Initiative is part of the investment promotion activity for the Vibrant Gujarat Regional conference.
Government of Gujarat to provide facilitation for obtaining all necessary departmental clearances.
Strategic move to strengthen logistics and export capabilities for salt products.

💡 Investors should monitor the progress of regulatory approvals and the construction timeline, as this jetty will likely reduce long-term logistics costs. This is a positive development for the company's margin profile and export scalability.

Archean Chemical Appoints Rampraveen Swaminathan as MD; P. Ranjit Elevated to Vice Chairman

🟢 POSITIVE ⭐ 7/10

MANAGEMENT 📅 10 Feb 2026, 05:53 PM

Archean Chemical Industries has initiated a postal ballot to seek shareholder approval for a significant leadership transition. Mr. Rampraveen Swaminathan is proposed as the new Managing Director for a five-year term effective January 22, 2026. Concurrently, the current Managing Director, Mr. P. Ranjit, will be elevated to the position of Executive Vice Chairman for a five-year tenure. The voting process for these appointments will conclude on March 12, 2026.

Appointment of Mr. Rampraveen Swaminathan as Managing Director for a 5-year term until January 2031
Elevation of current MD Mr. P. Ranjit to Executive Vice Chairman for a 5-year term starting January 22, 2026
Remote e-voting period set from February 11, 2026, to March 12, 2026
Cut-off date for shareholder voting eligibility established as February 06, 2026

💡 Investors should view this as a positive step toward professionalizing the management team with an experienced leader. Monitor upcoming earnings calls for any shifts in strategic direction under the new Managing Director.

Archean Chemical Industries Releases Q3 FY26 Earnings Call Recording

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 06 Feb 2026, 02:52 PM

Archean Chemical Industries has made the audio recording of its Q3 and nine-month FY26 earnings conference call available to the public. The call, held on February 6, 2026, discussed the company's un-audited financial performance for the period ending December 31, 2025. Investors can access the recording via the company's official website to gain insights into management's commentary on operations and future outlook. This filing is a standard regulatory requirement under SEBI (LODR) Regulations, 2015.

Earnings call conducted on February 6, 2026, at 11:30 AM IST.
Covers financial performance for Q3 and 9M ended December 31, 2025.
Audio recording link made available on the company's official investor relations portal.
Filing made in accordance with SEBI Listing Obligations and Disclosure Requirements.

💡 Investors should listen to the recording to understand management's perspective on volume growth and pricing trends. No immediate action is required based solely on this procedural filing.

Archean Chemical 9M FY26 Revenue Up 10.6% to ₹8,017 Mn; Salt Volumes Grow 39%

🔵 WATCH ⭐ 8/10

EARNINGS 📅 05 Feb 2026, 07:03 PM

Archean Chemical reported a 10.6% YoY increase in consolidated revenue to ₹8,016.7 million for 9M FY26, driven by a robust 29% growth in the Industrial Salt segment. However, consolidated PAT declined to ₹931.8 million from ₹1,084.0 million in the previous year, primarily due to a 22% drop in Bromine revenues caused by technical production issues. The company is aggressively diversifying into high-tech sectors, securing a 22.24% stake in UK-based Clas-Sic Wafer Fab and obtaining India Semiconductor Mission approval for a new SiC fab in Odisha. Exports remain a core strength, contributing 79% of total operating revenues.

9M FY26 Consolidated Revenue reached ₹8,016.7 million, up 10.6% YoY, while EBITDA stood at ₹2,166.5 million.
Industrial Salt volumes surged 39% to 3.07 million tons, contributing ₹5,329.8 million in revenue.
Bromine segment revenue declined 22% to ₹2,146.5 million as volumes fell 32% due to technical production challenges.
Strategic expansion into semiconductors via Clas-Sic Wafer Fab (UK) and a planned SiC fab in Odisha with ISM approval.
Bromine Derivatives (Acume Chemicals) volumes grew by 148% YoY, highlighting a shift toward value-added products.

💡 Investors should monitor the recovery of Bromine production efficiencies and the execution timeline of the semiconductor and energy storage pivots. While the salt business is performing well, margin recovery depends on stabilizing the high-margin Bromine segment.

Archean Chemical Q3 PAT Drops 39% YoY to ₹34.3 Cr; Revenue Up Slightly to ₹249.9 Cr

🔴 NEGATIVE ⭐ 8/10

EARNINGS 📅 04 Feb 2026, 08:00 PM

Archean Chemical Industries reported a marginal 3% YoY revenue growth to ₹249.9 crore for Q3 FY26, but net profit fell sharply by 39% to ₹34.3 crore due to rising operating costs. The company's 9-month performance was further weighed down by a ₹40.2 crore exceptional loss caused by Cyclone Asna damaging salt stocks. Investors should note the ongoing Income Tax investigation and the strategic pivot into semiconductors and battery tech through international investments. A significant management reshuffle has also taken place, including the appointment of a new Managing Director.

Revenue from operations increased 3% YoY to ₹249.9 crore in Q3 FY26.
Net Profit (PAT) declined significantly by 39% YoY to ₹34.3 crore from ₹56.3 crore.
Other expenses surged to ₹180.4 crore in Q3 FY26 compared to ₹160.6 crore in the year-ago period.
Exceptional loss of ₹40.2 crore recognized in 9M FY26 due to inventory loss from Cyclone Asna.
Strategic investments of GBP 15M in Clas-SiC (UK) and USD 12M in Offgrid Energy Labs (USA) are underway.

💡 Investors should remain cautious due to the sharp decline in profitability and the regulatory uncertainty surrounding the recent Income Tax search. Monitor the impact of the new management leadership and the progress of high-tech diversification into the semiconductor and battery sectors.

Archean Chemical Industries to Hold Q3 & 9M FY26 Earnings Call on February 6, 2026

🟡 NEUTRAL ⭐ 3/10

EARNINGS 📅 02 Feb 2026, 07:10 PM

Archean Chemical Industries Limited (ACI) has scheduled its earnings conference call for Friday, February 06, 2026, at 11:30 AM IST. The call will focus on the company's operational and financial performance for the third quarter and nine months ended December 31, 2025. Senior leadership, including the Executive Vice Chairman and Managing Director, will be present to interact with analysts and investors. This is a routine regulatory disclosure following the conclusion of the December quarter.

Earnings call scheduled for February 06, 2026, at 11:30 AM IST.
Agenda includes discussion of Q3 and 9M FY26 financial results.
Management participation includes Executive Vice Chairman Ranjit Pendurthi and MD Rampraveen Swaminathan.
Primary access numbers for the call are +91 22 6280 1309 and +91 22 7115 8210.

💡 Investors should monitor the call for management's outlook on bromine and industrial salt pricing. No immediate action is required as this is a routine scheduling announcement.

Archean Chemical Appoints Rampraveen Swaminathan as MD; P. Ranjit Moves to Executive Vice Chairman

🟢 POSITIVE ⭐ 8/10

MANAGEMENT 📅 19 Jan 2026, 06:58 PM

Archean Chemical Industries (ACI) has announced a major leadership restructuring aimed at professionalizing management for future growth. Mr. Rampraveen Swaminathan, former MD & CEO of Mahindra Logistics, has been appointed as the new Managing Director for a five-year term starting January 22, 2026. The current promoter-MD, Mr. P. Ranjit, will transition to the role of Executive Vice Chairman for a five-year term. Additionally, the company has appointed an Independent Director as Non-Executive Chairperson to strengthen its governance framework.

Appointment of Rampraveen Swaminathan (ex-Mahindra Logistics) as Managing Director for a 5-year term starting Jan 22, 2026
Promoter Mr. P. Ranjit transitioned from MD to Executive Vice Chairman for a 5-year term until Jan 2031
Mrs. Padma Chandrasekaran, Independent Director, designated as Non-Executive Chairperson to enhance governance
Resignation of Mr. N. R. Kannan (Executive Director) effective April 30, 2026, citing personal reasons

💡 The induction of a seasoned professional like Mr. Swaminathan from a large conglomerate is a positive signal for ACI's scaling and professionalization efforts. Investors should monitor the company's execution of expansion plans under this new leadership structure.

Archean Chemical Industries Submits SEBI Compliance Certificate for Q3 FY26

🟡 NEUTRAL ⭐ 2/10

ROUTINE 📅 09 Jan 2026, 03:39 PM

Archean Chemical Industries Limited has filed its quarterly compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018. The certificate, issued by MUFG Intime India Private Limited, confirms that all dematerialization requests for the quarter ended December 31, 2025, were processed within prescribed timelines. It further validates that the security certificates were mutilated and cancelled after due verification, and the name of the depositories was updated in the register of members. This is a standard administrative filing required by all listed companies in India.

Compliance certificate submitted for the quarter ended December 31, 2025
Issued by Registrar & Share Transfer Agent MUFG Intime India Private Limited
Confirms securities received for dematerialization were listed on stock exchanges
Physical certificates were mutilated and cancelled as per SEBI guidelines
Filing ensures the integrity of the company's shareholding records

💡 No action is required from investors as this is a routine regulatory filing. Focus should remain on the company's upcoming quarterly financial performance.

Archean Chemical to Close Trading Window from Jan 1, 2026 for Q3 FY26 Results

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 26 Dec 2025, 02:35 PM

Archean Chemical Industries Limited has announced the closure of its trading window starting January 1, 2026, in compliance with SEBI insider trading regulations. This closure is ahead of the finalization of the un-audited standalone and consolidated financial results for the quarter and nine months ending December 31, 2025. The restriction applies to designated persons and their immediate relatives and will remain in effect until 48 hours after the results are declared. The specific date for the board meeting to approve these results will be communicated at a later time.

Trading window closure effective from January 1, 2026.
Pertains to un-audited financial results for the quarter and nine months ending December 31, 2025.
Restriction applies to all designated persons and their immediate relatives as per SEBI norms.
Window will reopen 48 hours after the official announcement of financial results.

💡 This is a routine regulatory announcement with no direct impact on stock fundamentals. Investors should monitor for the upcoming board meeting date to prepare for the Q3 earnings release.

Archean Chemical Approves Rs 150 Cr Loan to Subsidiary for Semiconductor Project

🟢 POSITIVE ⭐ 8/10

EXPANSION 📅 20 Dec 2025, 12:08 PM

Archean Chemical Industries (ACI) has entered into a loan agreement to provide Rs 150 crore in interim funding to its wholly-owned subsidiary, Neun Infra Private Limited. This capital is earmarked for SiCSem Private Limited to procure long-lead machinery and support R&D for its semiconductor and ATMP manufacturing facility. The project has already received approval under the India Semiconductor Mission (ISM) framework. The loan carries an interest rate of 7.50% per annum, with repayment scheduled to begin in FY 2029-30.

Loan agreement of Rs 150 crore to support semiconductor project timelines and machinery procurement
Total loan facility granted to Neun Infra Private Limited stands at Rs 300 crore with Rs 157 crore currently outstanding
Funding supports SiCSem's R&D collaboration with IIT Bhubaneswar for silicon carbide technology
Interest rate set at 7.50% per annum with a 5-year repayment period starting from FY 2029-30
Project is strategically aligned with the India Semiconductor Mission (ISM) framework for compound semiconductors

💡 Investors should monitor the progress of the semiconductor facility as a long-term growth lever, though the project has a long gestation period. Watch for the formal execution of the Fiscal Support Agreement with the Government of India as the next major catalyst.

View All ACI Announcements on Live Market Tracking →

💰 Financial Performance

Revenue Growth by Segment

Consolidated revenue declined 28% to INR 1,042 Cr in FY25 from INR 1,339 Cr in FY24. For H1 FY26, the revenue mix was 31% Bromine and 68% Industrial Salt. The decline was driven by lower realizations and volumes in both Bromine and Industrial Salt segments.

Geographic Revenue Split

Not explicitly disclosed by region, but the company has a heavy export focus, particularly in liquid bromine where it maintains market leadership.

Profitability Margins

Operating margins moderated to 28.4% in FY25 from 36.2% in FY24 (a 19% decline in margin efficiency). Net Profit Margin was 24.2% in FY24, down 9% from 26.6% in FY23. Margins are expected to settle at 25-26% over the medium term due to gestational losses in new businesses.

EBITDA Margin

Operating Profit Margin was 37.2% in FY24 compared to 45.7% in FY23. The compression is attributed to weak bromine/salt realizations, higher freight costs, and increased power expenses.

Capital Expenditure

Historical capex was INR 200 Cr in FY24. Planned capex includes INR 150-200 Cr annually for FY25-26 for Bromine Phase 2 and Salt expansion. A major Semiconductor project (SPL) is valued at INR 2,066 Cr, funded 50% by the Central Govt, 25% by the Odisha Govt, and 25% by ACIL.

Credit Rating & Borrowing

CRISIL A-/Stable (upgraded from previous levels). Borrowing costs are low as the company was net debt-free post-IPO; however, debt is expected to peak at INR 550-600 Cr by FY28 to fund the semiconductor project.

⚙️ Operational Drivers

Raw Materials

Brine (natural resource) is the primary raw material, representing the bulk of input requirements. Other costs include power and chemicals used in the steaming-out process.

Import Sources

Sourced locally from leasehold land containing brine reserves, primarily in the Rann of Kutch, Gujarat.

Key Suppliers

Primarily self-sourced through government-leased land; however, the company relies on utility providers for power-intensive operations.

Capacity Expansion

Current industrial salt capacity is being expanded; a specialty product pilot plant with 130,000 tons per annum capacity is expected to be operational by Q4 FY26.

Raw Material Costs

Raw material costs are relatively low due to the cost-effective 'steaming out' process, but profitability is highly sensitive to the realization prices of the final products (Bromine and Salt).

Manufacturing Efficiency

The 'steaming out' process used for bromine extraction is more cost-effective than the 'blowing out' process used in China/Japan, providing a competitive cost advantage.

Logistics & Distribution

Distribution costs are significant due to the export-heavy nature of the business; higher freight costs in FY25 impacted operating profitability.

📈 Strategic Growth

Expected Growth Rate

8-10%

Growth Strategy

Growth will be driven by forward integration into high-margin bromine derivatives (Phase 1 & 2), expansion of industrial salt capacity, and diversification into the semiconductor sector (Silicon Carbide wafers) and energy storage (bromine-based batteries).

Products & Services

Liquid Bromine, Industrial Salt, Sulphate of Potash (SOP), Bromine Derivatives, and Silicon Carbide wafers.

Brand Portfolio

Archean Chemical Industries, Acume Chemicals (ACPL), Ideallis (OHPL).

New Products/Services

Bromine derivatives and Silicon Carbide wafers for the semiconductor industry; the latter is part of a massive INR 2,066 Cr investment.

Market Expansion

Targeting high-potential sectors like semiconductors and energy storage while deepening relationships with existing global clients like Sojitz.

Market Share & Ranking

Leading specialty chemical manufacturer and a top exporter of liquid bromine in India.

Strategic Alliances

Partnership with the Government of India and Government of Odisha for the semiconductor mission project (75% government funding).

🌍 External Factors

Industry Trends

The industry is shifting toward specialty derivatives. ACIL is positioning itself by moving from basic bromine to high-value derivatives and entering the semiconductor supply chain to capture higher margins.

Competitive Landscape

Moderate competitive intensity due to high capital requirements and long gestation periods; faces competition from global players in China and Israel.

Competitive Moat

Moat consists of access to limited natural brine resources, high entry barriers (4-5 year gestation for brine fields), and a low-cost production process. These are sustainable due to the scarcity of brine-rich land.

Macro Economic Sensitivity

Highly sensitive to global chemical demand and pricing cycles. GDP growth in end-user industries (agrochemicals, pharma, flame retardants) directly impacts demand.

Consumer Behavior

Increased demand for flame retardants and clear brine fluids in industrial applications is driving bromine consumption.

Geopolitical Risks

Trade barriers or shifts in Chinese/Japanese bromine production (competitors) could impact global supply-demand dynamics.

⚖️ Regulatory & Governance

Industry Regulations

Operations are subject to environmental norms and lease agreements with state governments for brine extraction. The semiconductor project is governed by the Indian Semiconductor Mission (ISM).

Environmental Compliance

High compliance requirement for brine extraction and chemical processing; non-renewal of leasehold land for brine reserves is a critical regulatory risk.

Taxation Policy Impact

Effective tax rate is standard corporate rate; however, the company is subject to ongoing scrutiny following an Income Tax search in September 2025.

Legal Contingencies

Income Tax Department search conducted in September 2025; as of the latest update, no formal demand or violation notices have been received, making the financial impact unknown.

⚠️ Risk Analysis

Key Uncertainties

Volatility in product realizations and project execution risks for the large-scale semiconductor plant (INR 2,066 Cr) could impact RoCE, which is expected to drop to 10% in FY26.